Familial pityriasis rubra pilaris successfully treated with brodalumab

Int J Dermatol. 2020 Jul;59(7):885-887. doi: 10.1111/ijd.14857. Epub 2020 Mar 23.

Authors

Catia De Felice¹, Dario Graceffa¹, Aldo Morrone², Claudio Bonifati¹

Affiliations

¹ Centre for the Study and Treatment of Psoriasis at the Department of Clinical Dermatology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
² Scientific Direction, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.

PMID: 32202311
DOI: 10.1111/ijd.14857

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Humans
Pityriasis Rubra Pilaris* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
brodalumab

Supplementary concepts

Familial pityriasis rubra pilaris